1. Home
  2. GMED vs NCLH Comparison

GMED vs NCLH Comparison

Compare GMED & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • NCLH
  • Stock Information
  • Founded
  • GMED 2003
  • NCLH 1966
  • Country
  • GMED United States
  • NCLH United States
  • Employees
  • GMED N/A
  • NCLH N/A
  • Industry
  • GMED Medical/Dental Instruments
  • NCLH Marine Transportation
  • Sector
  • GMED Health Care
  • NCLH Consumer Discretionary
  • Exchange
  • GMED Nasdaq
  • NCLH Nasdaq
  • Market Cap
  • GMED 11.6B
  • NCLH 12.1B
  • IPO Year
  • GMED 2012
  • NCLH 2013
  • Fundamental
  • Price
  • GMED $90.74
  • NCLH $27.17
  • Analyst Decision
  • GMED Buy
  • NCLH Buy
  • Analyst Count
  • GMED 13
  • NCLH 16
  • Target Price
  • GMED $95.42
  • NCLH $29.27
  • AVG Volume (30 Days)
  • GMED 1.2M
  • NCLH 8.2M
  • Earning Date
  • GMED 02-20-2025
  • NCLH 02-25-2025
  • Dividend Yield
  • GMED N/A
  • NCLH N/A
  • EPS Growth
  • GMED N/A
  • NCLH N/A
  • EPS
  • GMED 0.67
  • NCLH 1.25
  • Revenue
  • GMED $2,478,596,000.00
  • NCLH $9,356,741,000.00
  • Revenue This Year
  • GMED $62.39
  • NCLH $13.11
  • Revenue Next Year
  • GMED $6.71
  • NCLH $8.08
  • P/E Ratio
  • GMED $135.30
  • NCLH $21.73
  • Revenue Growth
  • GMED 102.10
  • NCLH 15.76
  • 52 Week Low
  • GMED $49.33
  • NCLH $14.69
  • 52 Week High
  • GMED $91.44
  • NCLH $28.64
  • Technical
  • Relative Strength Index (RSI)
  • GMED 74.99
  • NCLH 60.41
  • Support Level
  • GMED $86.28
  • NCLH $25.82
  • Resistance Level
  • GMED $91.44
  • NCLH $26.72
  • Average True Range (ATR)
  • GMED 1.99
  • NCLH 0.87
  • MACD
  • GMED 0.72
  • NCLH 0.12
  • Stochastic Oscillator
  • GMED 93.05
  • NCLH 87.20

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: